Qualitative Reasoning at Multiple Resolutions

Abstract

This phase 2 trial showed that TZT-1027 administered on days 1 and 8 of a 21-day cycle had no anticancer activity. Further development of TZT-1027 in patients with previously treated NSCLC is not warranted.

Cite

Text

Murthy. "Qualitative Reasoning at Multiple Resolutions." AAAI Conference on Artificial Intelligence, 1988. doi:10.1016/j.lungcan.2006.10.002

Markdown

[Murthy. "Qualitative Reasoning at Multiple Resolutions." AAAI Conference on Artificial Intelligence, 1988.](https://mlanthology.org/aaai/1988/murthy1988aaai-qualitative/) doi:10.1016/j.lungcan.2006.10.002

BibTeX

@inproceedings{murthy1988aaai-qualitative,
  title     = {{Qualitative Reasoning at Multiple Resolutions}},
  author    = {Murthy, Seshashayee S.},
  booktitle = {AAAI Conference on Artificial Intelligence},
  year      = {1988},
  pages     = {296-300},
  doi       = {10.1016/j.lungcan.2006.10.002},
  url       = {https://mlanthology.org/aaai/1988/murthy1988aaai-qualitative/}
}